Shiga toxin, cytolethal distending toxin, and hemolysin repertoires in clinical Escherichia coli O91 isolates

Journal of Clinical Microbiology

Volumn 47, Issue 7, 2009, Pages 2061-2066

  Bielaszewska, Martina ^a   Stoewe, Franziska ^a   Fruth, Angelika ^b   Zhang, Wenlan ^a   Prager, Rita ^b   Brockmeyer, Jens ^a   Mellmann, Alexander ^a   Karch, Helge ^a   Friedrich, Alexander W ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

^b ROBERT KOCH INSTITUTE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOLETHAL DISTENDING TOXIN; ELASTASE; HEMOLYSIN; SHIGA TOXIN;

ARTICLE; BACTERIAL GENETICS; BACTERIAL VIRULENCE; DIARRHEA; ENZYME ACTIVATION; ESCHERICHIA COLI; ESCHERICHIA COLI O91; GENE FREQUENCY; GENE LOCUS; GENETIC VARIABILITY; HEMOLYTIC UREMIC SYNDROME; NONHUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

BACTERIAL TOXINS; CELLS, CULTURED; CLUSTER ANALYSIS; DNA, BACTERIAL; ENDOTHELIAL CELLS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; HEMOLYSIN PROTEINS; HUMANS; LOCOMOTION; MOLECULAR SEQUENCE DATA; SEQUENCE ANALYSIS, DNA; SHIGA TOXIN; SHIGA-TOXIGENIC ESCHERICHIA COLI; VIRULENCE FACTORS;

ESCHERICHIA COLI;

EID: 67650066326     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00201-09     Document Type: Article

References (50)

1. Aldick, T., M. Bielaszewska, B. E. Uhlin, H.-U. Humpf, S. N. Wai, and H. Karch. 2009. Vesicular stabilization and activity augmentation of enterohaemorrhagic Escherichia coli haemolysin. Mol. Microbiol. 71:1496-1508.
2. Bettelheim, K. A. 2007. The non-O157 Shiga-toxigenic (verocytotoxigenic) Escherichia coli; under-rated pathogens. Crit. Rev. Microbiol. 33:67-87.
3. Beutin, L., and E. Strauch. 2007. Identification of sequence diversity in the Escherichia coli fliC genes encoding flagellar types H8 and H40 and its use in typing of Shiga toxin-producing E. coli O8, O22, O111, O174, and O179 strains. J. Clin. Microbiol. 45:333-339.
4. Bielaszewska, M., M. Fell, L. Greune, R. Prager, A. Fruth, H. Tschäpe, M. A. Schmidt, and H. Karch. 2004. Characterization of cytolethal distending toxin genes and expression in Shiga toxin-producing Escherichia coli strains of non-O157 serogroups. Infect. Immun. 72:1812-1816.
5. 2/M arrest, inhibition of proliferation, and death of human endothelial cells. Infect. Immun. 73:552-562.
6. Bielaszewska, M., W. Zhang, P. I. Tarr, A.-K. Sonntag, and H. Karch. 2005. Molecular profiling and phenotype analysis of Escherichia coli O26:H11 and O26:NM: secular and geographic consistency of enterohemorrhagic and enteropathogenic isolates. J. Clin. Microbiol. 43:4225-4228.
7. Bielaszewska, M., A. W. Friedrich, T. Aldick, R. Schurk-Bulgrin, and H. Karch. 2006. Shiga toxin activatable by intestinal mucus in Escherichia coli isolated from humans: predictor for a severe clinical outcome. Clin. Infect. Dis. 43:1160-1167.
8. Bielaszewska, M., R. Prager, L. Vandivinit, A. Müsken, A. Mellmann, N. J. Holt, P. I. Tarr, H. Karch, and W. Zhang. 2009. Detection and characterization of the fimbrial sfp cluster in enterohemorrhagic Escherichia coli O165:H25/NM isolates from humans and cattle. Appl. Environ. Microbiol. 75:64-71.
9. Bonnet, R., B. Souweine, G. Gauthier, C. Rich, V. Livrelli, J. Sirot, B. Joly, and C. Forestier. 1998. Non-O157:H7 Stx2-producing Escherichia coli strains associated with sporadic cases of hemolytic-uremic syndrome in adults. J. Clin. Microbiol. 36:1777-1780.
10. Brockmeyer, J., M. Bielaszewska, A. Fruth, M. L. Bonn, A. Mellmann, H.-U. Humpf, and H. Karch. 2007. Subtypes of the plasmid-encoded serine protease EspP in Shiga toxin-producing Escherichia coli: distribution, secretion, and proteolytic activity. Appl. Environ. Microbiol. 73:6351-6359.
11. Brooks, J. T., E. G. Sowers, J. G. Wells, K. D. Greene, P. M. Griffin, R. M. Hoekstra, and N. A. Strockbine. 2005. Non-O157 Shiga toxin-producing Escherichia coli infections in the United States, 1983-2002. J. Infect. Dis. 192:1422-1429.
12. Doughty, S., J. Sloan, V. Bennett-Wood, M. Robertson, R. M. Robins-Browne, and E. L. Hartland. 2002. Identification of a novel fimbrial gene cluster related to long polar fimbriae in locus of enterocyte effacement-negative strains of enterohemorrhagic Escherichia coli. Infect. Immun. 70: 6761-6769.
13. Eklund, M., F. Scheutz, and A. Siitonen. 2001. Clinical isolates of non-O157 Shiga toxin-producing Escherichia coli: serotypes, virulence characteristics, and molecular profiles of strains of the same serotype. J. Clin. Microbiol. 39:2829-2834.
14. Evans, J., A. Wilson, G. A. Willshaw, T. Cheasty, D. S. Tompkins, J. G. Wheeler, and H. R. Smith. 2002. Vero cytotoxin-producing Escherichia coli in a study of infectious intestinal disease in England. Clin. Microbiol. Infect. 8:183-186.
15. Fields, P. I., K. Blom, H. J. Hughes, L. O. Helsel, P. Feng, and B. Swaminathan. 1997. Molecular characterization of the gene encoding H antigen in Escherichia coli and development of a PCR-restriction fragment length polymorphism test for identification of E. coli O157:H7 and O157:NM. J. Clin. Microbiol. 35:1066-1070.
16. Friedrich, A. W., M. Bielaszewska, W. L. Zhang, M. Pulz, T. Kuczius, A. Ammon, and H. Karch. 2002. Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms. J. Infect. Dis. 185:74-84.
17. Friedrich, A. W., J. Borell, M. Bielaszewska, A. Fruth, H. Tschäpe, and H. Karch. 2003. Shiga toxin 1c-producing Escherichia coli strains: phenotypic and genetic characterization and association with human disease. J. Clin. Microbiol. 41:2448-2453.
18. -. J. Clin. Microbiol. 42:4697-4701.
19. Friedrich, A. W., S. Lu, M. Bielaszewska, R. Prager, P. Bruns, J.-G. Xu, H. Tschäpe, and H. Karch. 2006. Cytolethal distending toxin in Escherichia coli O157:H7: spectrum of conservation, structure, and endothelial toxicity. J. Clin. Microbiol. 44:1844-1846.
20. 2d) in Shiga toxigenic Escherichia coli from livestock sources. J. Clin. Microbiol. 41:3777-3783.
21. - and O157:H7: characterization and evolutionary considerations. Infect. Immun. 71:3634-3638.
22. Johnson, W. M., and H. Lior. 1988. A new heat-labile cytolethal distending toxin (CLDT) produced by Escherichia coli isolates from clinical material. Microb. Pathog. 4:103-113.
23. Karch, H., P. I. Tarr, and M. Bielaszewska. 2005. Enterohaemorrhagic Escherichia coli in human medicine. Int. J. Med. Microbiol. 295:405-418.
24. Kokai-Kun, J. F., A. R. Melton-Celsa, and A. D. O'Brien. 2000. Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d. J. Biol. Chem. 275:3713-3721.
25. Mellmann, A., M. Bielaszewska, L. B. Zimmerhackl, R. Prager, D. Harmsen, H. Tschape, and H. Karch. 2005. Enterohemorrhagic Escherichia coli in human infection: in vivo evolution of a bacterial pathogen. Clin. Infect. Dis. 41:785-792.
26. Mellmann, A., M. Bielaszewska, R. Köck, A. W. Friedrich, A. Fruth, B. Middendorf, D. Harmsen, M. A. Schmidt, and H. Karch. 2008. Analysis of collection of hemolytic uremic syndrome-associated enterohemorrhagic Escherichia coli. Emerg. Infect. Dis. 14:1287-1290.
27. Melton-Celsa, A. R., S. C. Darnell, and A. D. O'Brien. 1996. Activation of Shiga-like toxins by mouse and human intestinal mucus correlates with virulence of enterohemorrhagic Escherichia coli O91:H21 isolates in orally infected, streptomycin-treated mice. Infect. Immun. 64:1569-1576.
28. Melton-Celsa, A. R., J. F. Kokai-Kun, and A. D. O'Brien. 2002. Activation of Shiga toxin type 2d (Stx2d) by elastase involves cleavage of the C-terminal two amino acids of the A2 peptide in the context of the appropriate B pentamer. Mol. Microbiol. 43:207-215.
29. Müller, D., P. Hagedorn, S. Brast, G. Heusipp, M. Bielaszewska, A. W. Friedrich, H. Karch, and M. A. Schmidt. 2006. Rapid identification and differentiation of clinical isolates of enteropathogenic Escherichia coli (EPEC), atypical EPEC, and Shiga toxin-producing Escherichia coli by a one-step multiplex PCR method. J. Clin. Microbiol. 44:2626-2629.
30. Orth, D., K. Grif, M. P. Dierich, and R. Würzner. 2007. Variability in tellurite resistance and the ter gene cluster among Shiga toxin-producing Escherichia coli isolated from humans, animals and food. Res. Microbiol. 158:105-111.
31. Paton, A. W., P. Srimanote, M. C. Woodrow, and J. C. Paton. 2001. Characterization of Saa, a novel autoagglutinating adhesin produced by locus of enterocyte effacement-negative Shiga-toxigenic Escherichia coli strains that are virulent for humans. Infect. Immun. 69:6999-7009.
32. Paton, A. W., P. Srimanote, U. M. Talbot, H. Wang, and J. C. Paton. 2004. A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli. J. Exp. Med. 200:35-46.
33. Perelle, S., F. Dilasser, J. Grout, and P. Fach. 2004. Detection by 5′-nuclease PCR of Shiga-toxin producing Escherichia coli O26, O55, O91, O103, O111, O113, O145 and O157:H7, associated with the world's most frequent clinical cases. Mol. Cell. Probes 18:185-192.
34. Piérard, D., G. Muyldermans, L. Moriau, D. Stevens, and S. Lauwers. 1998. Identification of new verocytotoxin type 2 variant B-subunit genes in human and animal Escherichia coli isolates. J. Clin. Microbiol. 36:3317-3322.
35. Pradel, N., Y. Bertin, C. Martin, and V. Livrelli. 2008. Molecular analysis of Shiga toxin-producing Escherichia coli strains isolated from hemolytic-uremic syndrome patients and dairy samples in France. Appl. Environ. Microbiol. 74:2118-2128.
36. Prager, R., U. Strutz, A. Fruth, and H. Tschape. 2003. Subtyping of pathogenic Escherichia coli strains using flagellar H-antigens: serotyping versus fliC polymorphisms. Int. J. Med. Microbiol. 292:477-486.
37. Pulz, M., A. Matussek, M. Monazahian, A. Tittel, E. Nikolic, M. Hartmann, T. Bellin, J. Buer, and F. Gunzer. 2003. Comparison of a Shiga toxin enzyme-linked immunosorbent assay and two types of PCR for detection of Shiga toxin-producing Escherichia coli in human stool specimens. J. Clin. Microbiol. 41:4671-4675.
38. Rivas, M., E. Miliwebsky, I. Chinen, C. D. Roldán, L. Balbi, B. García, G. Fiorilli, S. Sosa-Estani, J. Kincaid, J. Rangel, P. M. Griffin, and the Case-Control Study Group. 2006. Characterization and epidemiologic subtyping of Shiga toxin-producing Escherichia coli strains isolated from hemolytic uremic syndrome and diarrhea cases in Argentina. Foodborne Pathog. Dis. 3:88-96.
39. Schmidt, H., W.-L. Zhang, U. Hemmrich, S. Jelacic, W. Brunder, P. I. Tarr, U. Dobrindt, J. Hacker, and H. Karch. 2001. Identification and characterization of a novel genomic island integrated at selC in locus of enterocyte effacement-negative, Shiga toxin-producing Escherichia coli. Infect. Immun. 69:6863-6873.
40. Seto, K., M. Taguchi, K. Kobayashi, and S. Kozaki. 2007. Biochemical and molecular characterization of minor serogroups of Shiga toxin-producing Escherichia coli isolated from humans in Osaka prefecture. J. Vet. Med. Sci. 69:1215-1222.
41. Sonntag, A.-K., R. Prager, M. Bielaszewska, W. Zhang, A. Fruth, H. Tschäpe, and H. Karch. 2004. Phenotypic and genotypic analyses of enterohemorrhagic Escherichia coli O145 strains from patients in Germany. J. Clin. Microbiol. 42:954-962.
42. Stins, M. F., F. Gilles, and K. S. Kim. 1997. Selective expression of adhesion molecules on human brain microvascular endothelial cells. J. Neuroimmunol. 76:81-90.
43. Tarr, P. I., S. S. Bilge, J. C. Vary, Jr., S. Jelacic, R. L. Habeeb, T. R. Ward, M. R. Baylor, and T. E. Besser. 2000. Iha: a novel Escherichia coli O157:H7 adherence-conferring molecule encoded on a recently acquired chromosomal island of conserved structure. Infect. Immun. 68:1400-1407.
44. Tarr, P. I., C. A. Gordon, and W. L. Chandler. 2005. Shiga toxin-producing Escherichia coli and the haemolytic uraemic syndrome. Lancet 365:1073-1086.
45. Teel, L. D., A. R. Melton-Celsa, C. K. Schmitt, and A. D. O'Brien. 2002. One of two copies of the gene for the activatable Shiga toxin type 2d in Escherichia coli O91:H21 strain B2F1 is associated with an inducible bacteriophage. Infect. Immun. 70:4282-4291.
46. Toma, C., E. Martinez Espinosa, T. Song, E. Miliwebsky, I. Chinen, S. Iyoda, M. Iwanaga, and M. Rivas. 2004. Distribution of putative adhesins in different seropathotypes of Shiga toxin-producing Escherichia coli. J. Clin. Microbiol. 42:4937-4946.
47. Werber, D., S. C. Behnke, A. Fruth, R. Merle, S. Menzler, S. Glaser, L. Kreienbrock, R. Prager, H. Tschäpe, P. Roggentin, L. Bockemühl, and A. Ammon. 2007. Shiga toxin-producing Escherichia coli infection in Germany: different risk factors for different age groups. Am. J. Epidemiol. 165:425-434.
48. Werber, D., L. Beutin, R. Pichner, K. Stark, and A. Fruth. 2008. Shiga toxin-producing Escherichia coli serogroups in food and patients, Germany. Emerg. Infect. Dis. 14:1803-1806.
49. Zhang, W., A. Mellmann, A. K. Sonntag, L. Wieler, M. Bielaszewska, H. Tschape, H. Karch, and A. W. Friedrich. 2007. Structural and functional differences between disease-associated genes of enterohaemorrhagic Escherichia coli O111. Int. J. Med. Microbiol. 297:17-26.
50. Zheng, J., S. Cui, L. D. Teel, S. Zhao, R. Singh, A. D. O'Brien, and J. Meng. 2008. Identification and characterization of Shiga toxin type 2 variants in Escherichia coli isolated from animals, food, and humans. Appl. Environ. Microbiol. 74:5645-5652.